RYVAX | VENAX | RYVAX / VENAX | |
Total Expense Ratio | 1.65 | 0.09 | 1,833% |
Annual Report Gross Expense Ratio | 1.68 | 0.09 | 1,867% |
Fund Existence | 27 years | 21 years | - |
Gain YTD | -16.728 | -0.881 | 1,899% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.35M | 8.78B | 0% |
Annual Yield % from dividends | 0.00 | 3.19 | - |
Returns for 1 year | -23.47 | -5.20 | 451% |
Returns for 3 years | -0.52 | 11.08 | -5% |
Returns for 5 years | 51.87 | 133.80 | 39% |
Returns for 10 years | -62.41 | 23.92 | -261% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NFEPX | 21.94 | -0.03 | -0.14% |
Columbia Large Cap Growth Opp Inst | |||
PMARX | 12.90 | -0.03 | -0.23% |
Victory Pioneer Equ Premium Income A | |||
ADCIX | 25.28 | -0.08 | -0.32% |
American Century Disciplined Growth I | |||
ELFNX | 97.46 | -0.32 | -0.33% |
Elfun Trusts | |||
VIGAX | 237.81 | -0.80 | -0.34% |
Vanguard Growth Index Admiral |